• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅觉阈值在早期活动期多发性硬化症中受损。

Olfactory threshold is impaired in early, active multiple sclerosis.

机构信息

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

出版信息

Mult Scler. 2011 Aug;17(8):964-9. doi: 10.1177/1352458511399798. Epub 2011 Mar 3.

DOI:10.1177/1352458511399798
PMID:21372115
Abstract

BACKGROUND

Olfactory dysfunction has been reported in multiple sclerosis (MS). However, to date no data are available on different qualities of olfactory function, namely odour identification, odour discrimination and odour perception threshold.

OBJECTIVE

To assess different qualities of olfactory function in patients with MS and correlate these with demographic data, clinical data, depression, quality of life and cognitive functions.

METHODS

In this cross-sectional study, 50 patients with MS or clinically isolated syndrome and 30 healthy controls were included. Olfactory function was measured using the Sniffin' Sticks test.

RESULTS

The scores for odour identification (p = 0.001), odour perception threshold (p = 0.037) and the combined score of odour identification, discrimination and perception threshold (TDI, p = 0.002) were significantly lower in MS. Hyposmia for identification (p = 0.0017), threshold (p = 0.017) and TDI score (p = 0.0014) was more frequent in MS. Olfactory threshold was impaired in patients who were clinically active in the previous year (p = 0.026) and in patients with a disease duration less than 2 years (p = 0.0093). Identification score was negatively correlated with disease duration (p = 0.0017). Olfactory function was not associated with disability, depression or quality of life.

CONCLUSIONS

We report evidence for qualitatively distinct hyposmia in MS, with increased smell threshold in the early inflammatory phases of the disease and impaired identification with a more widespread chronic disease.

摘要

背景

嗅觉功能障碍已在多发性硬化症(MS)中报道。然而,迄今为止,尚无关于嗅觉功能不同质量的数据,即气味识别、气味辨别和气味感知阈值。

目的

评估 MS 患者不同的嗅觉功能,并将其与人口统计学数据、临床数据、抑郁、生活质量和认知功能相关联。

方法

在这项横断面研究中,纳入了 50 名 MS 或临床孤立综合征患者和 30 名健康对照者。使用 Sniffin' Sticks 测试评估嗅觉功能。

结果

MS 患者的气味识别评分(p=0.001)、气味感知阈值评分(p=0.037)和气味识别、辨别和感知阈值综合评分(TDI,p=0.002)均显著降低。MS 患者的嗅觉识别障碍(p=0.0017)、阈值障碍(p=0.017)和 TDI 评分障碍(p=0.0014)更为常见。嗅觉阈值在过去一年有临床活动的患者(p=0.026)和疾病持续时间小于 2 年的患者(p=0.0093)中受损。识别评分与疾病持续时间呈负相关(p=0.0017)。嗅觉功能与残疾、抑郁或生活质量无关。

结论

我们报告了 MS 中存在定性不同的嗅觉障碍的证据,疾病早期炎症阶段的嗅觉阈值增加,而慢性疾病更为广泛时,识别能力受损。

相似文献

1
Olfactory threshold is impaired in early, active multiple sclerosis.嗅觉阈值在早期活动期多发性硬化症中受损。
Mult Scler. 2011 Aug;17(8):964-9. doi: 10.1177/1352458511399798. Epub 2011 Mar 3.
2
Olfactory and gustatory function in patients with multiple sclerosis.多发性硬化症患者的嗅觉和味觉功能。
Am J Rhinol Allergy. 2010 Sep-Oct;24(5):e93-7. doi: 10.2500/ajra.2010.24.3506.
3
Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function.多发性硬化症中的嗅觉功能障碍:嗅觉功能不同方面下降的证据。
Eur Neurol. 2013;69(3):166-70. doi: 10.1159/000345482. Epub 2012 Dec 19.
4
Olfactory function in patients with multiple sclerosis: a diffusion tensor imaging study.多发性硬化症患者的嗅觉功能:一项弥散张量成像研究。
J Neurol Sci. 2012 May 15;316(1-2):56-60. doi: 10.1016/j.jns.2012.01.031. Epub 2012 Feb 17.
5
Olfactory function in primary open-angle glaucoma patients.原发性开角型青光眼患者的嗅觉功能
Klin Monbl Augenheilkd. 2010 Apr;227(4):277-9. doi: 10.1055/s-0029-1245198. Epub 2010 Apr 20.
6
Psychophysiological and electrophysiological testing of olfactory and gustatory function in patients with multiple sclerosis.多发性硬化症患者嗅觉和味觉功能的心理生理学和电生理学测试。
Eur Arch Otorhinolaryngol. 2012 Apr;269(4):1163-9. doi: 10.1007/s00405-011-1812-7. Epub 2011 Nov 6.
7
Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration.嗅觉多发性硬化症:不同嗅觉功能的质量反映了炎症活动或神经退行性变。
Mult Scler. 2020 Jan;26(1):57-68. doi: 10.1177/1352458518814113. Epub 2018 Nov 22.
8
Reduced olfactory sensitivity, discrimination, and identification in patients with alcohol dependence.酒精依赖患者嗅觉敏感性、辨别力和识别力降低。
Alcohol Clin Exp Res. 2003 Mar;27(3):432-9. doi: 10.1097/01.ALC.0000057945.57330.2C.
9
Validation study of the "Sniffin' Sticks" olfactory test in a British population: a preliminary communication.“嗅探棒”嗅觉测试在英国人群中的验证研究:初步交流。
Clin Otolaryngol. 2012 Feb;37(1):23-7. doi: 10.1111/j.1749-4486.2012.02431.x.
10
Change of olfactory function as a marker of inflammatory activity and disability progression in MS.嗅觉功能变化可作为 MS 炎症活动和残疾进展的标志物。
Mult Scler. 2019 Feb;25(2):267-274. doi: 10.1177/1352458517745724. Epub 2017 Nov 29.

引用本文的文献

1
Neuroinflammation causes mitral cell dysfunction and olfactory impairment in a multiple sclerosis model.在多发性硬化症模型中,神经炎症会导致僧帽细胞功能障碍和嗅觉损伤。
J Neuroinflammation. 2025 Mar 8;22(1):71. doi: 10.1186/s12974-025-03388-5.
2
Alzheimer's disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS.多发性硬化症(MS)中的阿尔茨海默病(AD):已发表病例的系统综述、AD与MS之间的机制联系以及MS中AD可能的临床评估
J Alzheimers Dis Rep. 2025 Jan 31;9:25424823251316134. doi: 10.1177/25424823251316134. eCollection 2025 Jan-Dec.
3
Persistent Post-COVID-19 Olfactory Dysfunction and Its Association with Autonomic Nervous System Function: A Case-Control Study.
新冠后持续性嗅觉功能障碍及其与自主神经系统功能的关联:一项病例对照研究
Diseases. 2024 Dec 28;13(1):4. doi: 10.3390/diseases13010004.
4
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis.气味辨别和识别作为多发性硬化长期残疾恶化的生物标志物。
Mult Scler. 2024 Jan;30(1):55-62. doi: 10.1177/13524585231201093. Epub 2023 Oct 18.
5
Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.了解多发性硬化症非运动症状的范围:来自动物模型的见解。
Neural Regen Res. 2024 Jan;19(1):84-91. doi: 10.4103/1673-5374.375307.
6
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?针对神经炎症以减轻长新冠中的慢性嗅觉功能障碍:研究疾病修正疗法(DMT)的作用?
Life (Basel). 2023 Jan 13;13(1):226. doi: 10.3390/life13010226.
7
Neuronal Adenosine A Receptor is Critical for Olfactory Function but Unable to Attenuate Olfactory Dysfunction in Neuroinflammation.神经元腺苷A受体对嗅觉功能至关重要,但在神经炎症中无法减轻嗅觉功能障碍。
Front Cell Neurosci. 2022 Jun 30;16:912030. doi: 10.3389/fncel.2022.912030. eCollection 2022.
8
Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.多发性硬化症患者的嗅觉功能障碍:系统评价和荟萃分析。
PLoS One. 2022 Apr 19;17(4):e0266492. doi: 10.1371/journal.pone.0266492. eCollection 2022.
9
International consensus statement on allergy and rhinology: Olfaction.国际过敏与鼻科学学会共识声明:嗅觉。
Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929.
10
Comparative Study of Brain fMRI of Olfactory Stimulation in Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis.视神经脊髓炎谱系疾病与多发性硬化症嗅觉刺激的脑功能磁共振成像对比研究
Front Neurosci. 2022 Jan 10;15:813157. doi: 10.3389/fnins.2021.813157. eCollection 2021.